Bioabsorbable Stents Market: Opportunities and Challenges

 Breaking News
  • No posts were found

Bioabsorbable Stents Market: Opportunities and Challenges

November 09
18:06 2019
Bioabsorbable Stents Market: Opportunities and Challenges

Some prominent players in the bioabsorbable stents market include Abbott (US), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (US), Elixir Medical Corporation (US), Arterial Remodeling Technologies (France), and Kyoto Medical Planning Co., Ltd. (Japan).
The increasing patient population in emerging markets is also expected to influence the market positively in the coming years.

The global Bioabsorbable Stents Market is expected to reach USD 417.2 million by 2022 from USD 242.4 million in 2017, at a CAGR of 11.5% during the forecast period, as per a report by MarketsandMarkets. 

Why emerging markets could offer high-growth opportunities for market participants?

At present, emerging nations such as India, China, and Brazil are one of the biggest markets for bioresorbable stents across the globe. Increasing disposable incomes in these countries have resulted in growing access to and affordability of quality healthcare for a larger population base. The increasing patient population in emerging markets is also expected to influence the market positively in the coming years.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40983380

According to eHealth, it is estimated that by 2030, the prevalence of cardiovascular disease would increase by nearly 73% in China. This presents immense opportunities for manufacturers of bioresorbable stents.

To cater to the increasing demand in the emerging markets, various companies are increasingly focusing on developing bioresorbable stents to be used for treating CAD and PAD. For example, SMT and Meril Life Sciences (India) are developing fully bioresorbable stents. Elixir Medical Corporation (U.S.) and REVA Medical, Inc. (U.S.) have carried out clinical trials of their products in Brazil.

How high risk of complications remain a challenge?

There are several complications associated with bioresorbable stents commercially available in the market. Companies, however, are continuously looking to adopt and implement effective ways to reduce the risk of complications caused by these devices.

A major complication is the high risk of stent thrombosis. For instance, when biovascular scaffolds (BVS) were tested against drug-eluting metal (DEM) stents in a meta-analysis, BVS showed 80% higher chances of stent thrombosis. Stent thrombosis is a condition where an earlier implanted stent in a coronary artery becomes blocked by a blood clot.

Some other complications associated with bioresorbable stents include recoiling of stents and inflammation caused due to prolonged exposure of polymers to vessels.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=40983380

These complications pose a major challenge to companies launching bioresorbable stents in the market.

Browse Related Reports:

Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) – Global Forecast to 2022

Coronary Stent Market by Type (BMS, BVS, Drug Eluting), Mode of Delivery (Self, Balloon Expandable), Material (Metal (Stainless Steel, CoCr, PtCr, Nitinol), Polymer, Copolymer), & End User (Hospital, Cardiology Center, ASC) – Global Forecasts to 2021

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Shelly Singh
Email: Send Email
Phone: 1-888-600-6441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/bioabsorbable-stent-market-40983380.html